Cell cycle-regulatory cyclins and their deregulation in oral cancer

Oral Oncology

Volumn 49, Issue 6, 2013, Pages 475-481

  Mishra, Rajakishore ^a  

^a CENTRAL UNIVERSITY OF JHARKHAND   (India)

Author keywords

Cyclin A; Cyclin B; Cyclin D; Cyclin E; Oral cancer; OSCC; Regulation of cyclins

Indexed keywords

ANAPHASE PROMOTING COMPLEX; BETA CATENIN; CARCINOGEN; CYCLIN A; CYCLIN A1; CYCLIN A2; CYCLIN B; CYCLIN D; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN E; CYCLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN MDM2; PROTEIN P27; PROTEIN P53; STAT3 PROTEIN; STAT5A PROTEIN; TRANSCRIPTION FACTOR AP 1; WNT PROTEIN;

CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CHEEK MUCOSA; CHROMOSOME 19Q; DISEASE SEVERITY; DNA METHYLATION; EPITHELIUM CELL; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION; UPREGULATION;

CELL CYCLE PROTEINS; CELL NUCLEUS; CYCLINS; CYTOPLASM; HUMANS; MOUTH NEOPLASMS; PROTEIN TRANSPORT;

EID: 84877061630     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.01.008     Document Type: Review

References (139)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2 2011 69 90
2. C. Scully, and S. Porter ABC of oral health. Swellings and red, white, and pigmented lesions BMJ 321 7255 2000 225 228
3. R. Mishra, and B.R. Das Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression Arch Oral Biol 54 10 2009 917 923
4. C. Scully, and J.V. Bagan Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes Oral Oncol 45 6 2009 e25 30
5. Y. Cai, Y.F. Liu, S.L. Li, Y.X. Pan, Y. Zhu, and Y.N. Yu Cyclin E overexpression and centrosome amplification in squamous cell carcinoma of oral cavity Zhonghua Bing Li Xue Za Zhi 36 6 2007 375 378
6. M. Rodriguez-Pinilla, J.L. Rodriguez-Peralto, R. Hitt, J.J. Sanchez, C. Ballestin, and A. Diez Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer Clin Cancer Res 10 24 2004 8486 8492
7. J. Kushner, G. Bradley, B. Young, and R.C. Jordan Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma J Oral Pathol Med 28 2 1999 77 81
8. Y. Xiong, T. Connolly, B. Futcher, and D. Beach Human D-type cyclin Cell 65 4 1991 691 699
9. A. Koff, A. Giordano, D. Desai, K. Yamashita, J.W. Harper, and S. Elledge Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle Science 257 5077 1992 1689 1694
10. M. Pagano, R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta Cyclin A is required at two points in the human cell cycle EMBO J 11 3 1992 961 971
11. S. Geley, E. Kramer, C. Gieffers, J. Gannon, J.M. Peters, and T. Hunt Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint J Cell Biol 153 1 2001 137 148
12. N. den Elzen, and J. Pines Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase J Cell Biol 153 1 2001 121 136
13. J. Pines, and T. Hunter Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2 Cell 58 5 1989 833 846
14. J. Bartkova, J. Lukas, H. Muller, M. Strauss, B. Gusterson, and J. Bartek Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer Cancer Res 55 4 1995 949 956
15. G. Martin-Ezquerra, R. Salgado, A. Toll, M. Gilaberte, T. Baro, and Alameda Quitllet Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours Br J Dermatol 163 5 2010 1028 1035
16. S.N. Das, P. Khare, M.K. Singh, and S.C. Sharma Correlation of cyclin D1 expression with aggressive DNA pattern in patients with tobacco-related intraoral squamous cell carcinoma Indian J Med Res 133 2011 381 386
17. R.P. Takes, R.J. BaatenburgdeJong, K. Wijffels, E. Schuuring, S.V. Litvinov, and J. Hermans Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer J Pathol 194 3 2001 298 302
18. S.F. Huang, S.D. Cheng, W.Y. Chuang, I.H. Chen, C.T. Liao, and H.M. Wang Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma World J Surg Oncol 10 2012 40
19. T. Shpitzer, Y. Hamzany, G. Bahar, R. Feinmesser, D. Savulescu, and I. Borovoi Salivary analysis of oral cancer biomarkers Br J Cancer 101 7 2009 1194 1198
20. K. Myo, N. Uzawa, R. Miyamoto, I. Sonoda, Y. Yuki, and T. Amagasa Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity Cancer 104 12 2005 2709 2716
21. K. Freier, K. Knoepfle, C. Flechtenmacher, S. Pungs, F. Devens, and G. Toedt Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma Genes Chromosomes Cancer 49 1 2010 9 16
22. M. Iyoda, A. Kasamatsu, T. Ishigami, D. Nakashima, Y. Endo-Sakamoto, and K. Ogawara Epithelial cell transforming sequence 2 in human oral cancer PLoS One 5 11 2010 e14082
23. R.J. Oliver, and D.G. MacDonald G1 cyclins in oral epithelial dysplasia J Oral Pathol Med 30 2 2001 80 86
24. R. Ito, W. Yasui, Y. Ogawa, S. Toyosawa, E. Tahara, and N. Ijuhin Reduced expression of cyclin-dependent kinase inhibitor p27(Kip1) in oral malignant tumors Pathobiology 67 4 1999 169 173
25. M. Ritta, M. De Andrea, M. Mondini, J. Mazibrada, C. Giordano, and G. Pecorari Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression Head Neck 31 3 2009 318 327
26. D.C. Nguyen, B. Parsa, A. Close, B. Magnusson, D.L. Crowe, and U.K. Sinha Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas Int J Oncol 22 6 2003 1285 1290
27. Y. Tokumaru, K. Yamashita, M. Osada, S. Nomoto, D.I. Sun, and Y. Xiao Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing Cancer Res 64 17 2004 5982 5987
28. R.D. Farhadieh, R. Smee, C.G. Rees, A. Salardini, S. Eggleton, and J.L. Yang Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck ANZ J Surg 79 1-2 2009 48 54
29. Q. Chen, H. Zhou, W. Guo, L.P. Samaranayake, M. Zhou, and B. Li Correlation between the expression of cyclin A protein and p53 activity in oral squamous cell carcinomas Cytobios 106 412 2001 87 99
30. M. Mihara, S. Shintani, Y. Nakahara, A. Kiyota, Y. Ueyama, and T. Matsumura Overexpression of CDK2 is a prognostic indicator of oral cancer progression Jpn J Cancer Res 92 3 2001 352 360
31. R.J. Oliver, and D.G. MacDonald Comparison of BrdU and cyclin A as markers of the S-phase in oral precancerous lesions J Oral Pathol Med 29 9 2000 426 431
32. O. Hamadah, M.L. Goodson, and P.J. Thomson Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions Br J Oral Maxillofac Surg 48 7 2010 503 506
33. M. Lotayef, G.D. Wilson, F.M. Daley, H.K. Awwad, and T. Shouman Aberrant expression of cyclin A in head and neck cancer Br J Cancer 83 1 2000 30 34
34. P.J. Thomson, O. Hamadah, M.L. Goodson, N. Cragg, and C. Booth Predicting recurrence after oral precancer treatment: use of cell cycle analysis Br J Oral Maxillofac Surg 46 5 2008 370 375
35. K.A. Hassan, K.K. Ang, A.K. El-Naggar, M.D. Story, J.I. Lee, and D. Liu Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma Cancer Res 62 22 2002 6414 6417
36. K.A. Hassan, A.K. El-Naggar, J.C. Soria, D. Liu, W.K. Hong, and L. Mao Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue Clin Cancer Res 7 8 2001 2458 2462
37. S. Watanabe, R. Watanabe, A.F. Oton-Leite, C. AlencarRde, J.C. Oliveira, and C.R. Leles Analysis of cell proliferation and pattern of invasion in oral squamous cell carcinoma J Oral Sci 52 3 2010 417 424
38. H. Harada, K. Omura, Y. Nakajima, S. Hasegawa, and S. Mogi Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma J Exp Clin Cancer Res 25 3 2006 351 356
39. K. Okami, A.L. Reed, P. Cairns, W.M. Koch, W.H. Westra, and S. Wehage Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma Oncogene 18 23 1999 3541 3545
40. R. Mishra, and B. Das Activation of STAT5-cyclin D1 pathway in chewing tobacco mediated oral squamous cell carcinoma Mol Biol Rep 32 3 2005 159 166
41. H.S. Liu, H.H. Lu, M.T. Lui, E.H. Yu, W. Shen, and Y.P. Chen Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers Oral Oncol 45 12 2009 1032 1036
42. H.M. Mahdey, A. Ramanathan, S.M. Ismail, M.T. Abraham, M. Jamaluddin, and R.B. Zain Cyclin D1 amplification in tongue and cheek squamous cell carcinoma Asian Pac J Cancer Prev 12 9 2011 2199 2204
43. K.M. Sathyan, K.R. Nalinakumari, T. Abraham, and S. Kannan CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma Oral Oncol 44 7 2008 689 697
44. C.C. Gomes, S.N. Drummond, A.L. Guimaraes, C.I. Andrade, R.A. Mesquita, and R.S. Gomez P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma J Oral Pathol Med 37 3 2008 151 156
45. S.L. Holley, C. Matthias, V. Jahnke, A.A. Fryer, R.C. Strange, and P.R. Hoban Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma Oral Oncol 41 2 2005 156 160
46. Z. Yu, C. Wang, M. Wang, Z. Li, M.C. Casimiro, and M. Liu A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation J Cell Biol 182 3 2008 509 517
47. C. Geisen, and T. Moroy The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein J Biol Chem 277 42 2002 39909 39918
48. M. Marone, G. Scambia, C. Giannitelli, G. Ferrandina, V. Masciullo, and A. Bellacosa Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression Int J Cancer 75 1 1998 34 39
49. K. Keyomarsi, and A.B. Pardee Redundant cyclin overexpression and gene amplification in breast cancer cells Proc Natl Acad Sci USA 90 3 1993 1112 1116
50. W.W. Lockwood, D. Stack, T. Morris, D. Grehan, C. O'Keane, and G.L. Stewart Cyclin E1 is amplified and overexpressed in osteosarcoma J Mol Diagn 13 3 2011 289 296
51. M. Scaltriti, P.J. Eichhorn, J. Cortes, L. Prudkin, C. Aura, and J. Jimenez Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients Proc Natl Acad Sci USA 108 9 2011 3761 3766
52. W.A. Bresnahan, T. Albrecht, and E.A. Thompson The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein J Biol Chem 273 34 1998 22075 22082
53. S. Sahin, I. Saygun, A. Kubar, and J. Slots Periodontitis lesions are the main source of salivary cytomegalovirus Oral Microbiol Immunol 24 4 2009 340 342
54. J. Bondi, A. Husdal, G. Bukholm, J.M. Nesland, A. Bakka, and I.R. Bukholm Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome J Clin Pathol 58 5 2005 509 514
55. C. Muller, C. Readhead, S. Diederichs, G. Idos, R. Yang, and N. Tidow Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent Mol Cell Biol 20 9 2000 3316 3329
56. J. Wang, F. Zindy, X. Chenivesse, E. Lamas, B. Henglein, and C. Brechot Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma Oncogene 7 8 1992 1653 1656
57. K. Pillay, H. McCleod, R. Chetty, and P. Hall A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma World J Surg Oncol 9 2011 31
58. A.K. Singh, M. Swarnalatha, and V. Kumar C-ETS1 facilitates G1/S-phase transition by up-regulating cyclin E and CDK2 genes and cooperates with hepatitis B virus X protein for their deregulation J Biol Chem 286 25 2011 21961 21970
59. L. Liu, J.N. Rao, T. Zou, L. Xiao, A. Smith, and R. Zhuang Activation of Wnt3a signaling stimulates intestinal epithelial repair by promoting c-Myc-regulated gene expression Am J Physiol Cell Physiol 302 1 2012 C277 285
60. D.P. Ding, Z.L. Chen, X.H. Zhao, J.W. Wang, J. Sun, and Z. Wang MiR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression Carcinogenesis 32 7 2011 1025 1032
61. M. Ofir, D. Hacohen, and D. Ginsberg MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E Mol Cancer Res 9 4 2011 440 447
62. C.E. Caldon, C.M. Sergio, J. Kang, A. Muthukaruppan, M.N. Boersma, and A. Stone Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells Mol Cancer Ther 11 7 2012 1488 1499
63. A. Schulze, K. Zerfass, D. Spitkovsky, S. Middendorp, J. Berges, and K. Helin Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site Proc Natl Acad Sci USA 92 24 1995 11264 11268
64. R.A. Kwong, T.V. Nguyen, R.J. Bova, J.G. Kench, I.E. Cole, and E.A. Musgrove Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue Clin Cancer Res 9 10 Pt 1 2003 3705 3711
65. L.L. Hsieh, P.F. Wang, I.H. Chen, C.T. Liao, H.M. Wang, and M.C. Chen Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese Carcinogenesis 22 9 2001 1497 1503
66. C. Badie, J. Bourhis, J. Sobczak-Thepot, H. Haddada, M. Chiron, and M. Janicot P53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line Br J Cancer 82 3 2000 642 650
67. M. Yoshizumi, H. Wang, C.M. Hsieh, N.E. Sibinga, M.A. Perrella, and M.E. Lee Down-regulation of the cyclin A promoter by transforming growth factor-beta1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein J Biol Chem 272 35 1997 22259 22264
68. J. Katz, A. Jakymiw, M.K. Ducksworth, C.M. Stewart, I. Bhattacharyya, and S. Cha CIP2A expression and localization in oral carcinoma and dysplasia Cancer Biol Ther 10 7 2010 694 699
69. M.R. Junttila, P. Puustinen, M. Niemela, R. Ahola, H. Arnold, and T. Bottzauw CIP2A inhibits PP2A in human malignancies Cell 130 1 2007 51 62
70. R. Baral, S. Patnaik, and B.R. Das Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India Eur J Oral Sci 106 5 1998 907 913
71. R. Mishra, and B.R. Das Early overexpression of Cdk4 and possible role of KRF and c-myc in chewing tobacco mediated oral cancer development Mol Biol Rep 30 4 2003 207 213
72. J.D. Cha, S. Li, and I.H. Cha Association between expression of embryonic lethal abnormal vision-like protein HuR and cyclooxygenase-2 in oral squamous cell carcinoma Head Neck 2010
73. H. Hasegawa, W. Kakuguchi, T. Kuroshima, T. Kitamura, S. Tanaka, and Y. Kitagawa HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells Br J Cancer 100 12 2009 1943 1948
74. W. Kakuguchi, T. Kitamura, T. Kuroshima, M. Ishikawa, Y. Kitagawa, and Y. Totsuka HuR knockdown changes the oncogenic potential of oral cancer cells Mol Cancer Res 8 4 2010 520 528
75. R.X. Yu, X.M. Hu, S.Q. Xu, Z.J. Jiang, and W. Yang Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway Eur J Pharmacol 657 1-3 2011 10 19
76. J.K. Nagpal, R. Mishra, and B.R. Das Activation of Stat-3 as one of the early events in tobacco chewing-mediated oral carcinogenesis Cancer 94 9 2002 2393 2400
77. Y. Li, D.Y. Zhang, Q. Ren, F. Ye, X. Zhao, and G. Daniels Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching Mol Cell Biol 32 13 2012 2454 2466
78. N. Gustafsson, C. Zhao, J.A. Gustafsson, and K. Dahlman-Wright RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1 Cancer Res 70 3 2010 1265 1274
79. K. Nelson, V. Helmstaedter, and H. Lage The influence of tamoxifen on growth behavior and cell-cell adhesion in OSCC in vitro Oral Oncol 43 7 2007 720 727
80. K.C. Kim, W.J. Oh, K.H. Ko, C.Y. Shin, and D.G. Wells Cyclin B1 expression regulated by cytoplasmic polyadenylation element binding protein in astrocytes J Neurosci 31 34 2011 12118 12128
81. V. Huang, R.F. Place, V. Portnoy, J. Wang, Z. Qi, and Z. Jia Upregulation of Cyclin B1 by miRNA and its implications in cancer Nucl Acids Res 40 4 2012 1695 1707
82. J.H. Zhang, L.M. Panicker, E.M. Seigneur, L. Lin, C.D. House, and W. Morgan Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73 Cell Death Differ 17 10 2010 1551 1565
83. M. Huang, M.R. Spitz, J. Gu, J.J. Lee, J. Lin, and S.M. Lippman Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions Carcinogenesis 27 10 2006 2034 2037
84. R. Mathew, S. Arora, R. Khanna, N.K. Shukla, M. Mathur, and R. Ralhan Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population J Cancer Res Clin Oncol 127 4 2001 251 257
85. K.E. Knudsen, J.A. Diehl, C.A. Haiman, and E.S. Knudsen Cyclin D1: polymorphism, aberrant splicing and cancer risk Oncogene 25 11 2006 1620 1628
86. Y. Ye, S.M. Lippman, J.J. Lee, M. Chen, M.L. Frazier, and M.R. Spitz Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions Cancer 113 9 2008 2488 2495
87. Y.T. Kwak, R. Li, C.R. Becerra, D. Tripathy, E.P. Frenkel, and U.N. Verma IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation J Biol Chem 280 40 2005 33945 33952
88. G. Maeda, T. Chiba, S. Kawashiri, T. Satoh, and K. Imai Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression Clin Cancer Res 13 17 2007 5041 5047
89. H. Goto, K. Kawano, I. Kobayashi, H. Sakai, and S. Yanagisawa Expression of cyclin D1 and GSK-3beta and their predictive value of prognosis in squamous cell carcinomas of the tongue Oral Oncol 38 6 2002 549 556
90. R. Mishra Glycogen synthase kinase 3 beta: can it be a target for oral cancer Mol Cancer 9 1 2010 144
91. N. Siddavaram, V.P. Ramamurthi, V. Veeran, and R. Mishra Chlorophyllin abrogates canonical Wnt/beta-catenin signaling and angiogenesis to inhibit the development of DMBA-induced hamster cheek pouch carcinomas Cell Oncol (Dordr) 35 5 2012 385 395
92. J.A. Diehl, M. Cheng, M.F. Roussel, and C.J. Sherr Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization Genes Dev 12 22 1998 3499 3511
93. H. Wingate, A. Puskas, M. Duong, T. Bui, D. Richardson, and Y. Liu Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression Cell Cycle 8 7 2009 1062 1068
94. M.F. Buckley, K.J. Sweeney, J.A. Hamilton, R.L. Sini, D.L. Manning, and R.I. Nicholson Expression and amplification of cyclin genes in human breast cancer Oncogene 8 8 1993 2127 2133
95. M. Lerner, J. Lundgren, S. Akhoondi, A. Jahn, H.F. Ng, and F. Akbari Moqadam MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression Cell Cycle 10 13 2011 2172 2183
96. K.T. Siu, M.R. Rosner, and A.C. Minella An integrated view of cyclin E function and regulation Cell Cycle 11 1 2012 57 64
97. M. Welcker, J. Singer, K.R. Loeb, J. Grim, A. Bloecher, and M. Gurien-West Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation Mol Cell 12 2 2003 381 392
98. J. Hou, X. Wang, Y. Li, X. Liu, Z. Wang, and J. An 17beta-estradiol induces both up-regulation and processing of cyclin E in a calpain-dependent manner in MCF-7 breast cancer cells FEBS Lett 586 6 2012 892 896
99. C.H. Yam, W.Y. Siu, A. Lau, and R.Y. Poon Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2 J Biol Chem 275 5 2000 3158 3167
100. P. Ji, D. Sun, H. Wang, F. Bauzon, and L. Zhu Disrupting Skp2-cyclin A interaction with a blocking peptide induces selective cancer cell killing Mol Cancer Ther 6 2 2007 684 691
101. G. Mondal, S. Sengupta, C.K. Panda, S.M. Gollin, W.S. Saunders, and S. Roychoudhury Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer Carcinogenesis 28 1 2007 81 92
102. L. Qin, T. Tong, Y. Song, L. Xue, F. Fan, and Q. Zhan Aurora-A interacts with Cyclin B1 and enhances its stability Cancer Lett 275 1 2009 77 85
103. C. Pan, M. Yan, J. Yao, J. Xu, Z. Long, and H. Huang Aurora kinase small molecule inhibitor destroys mitotic spindle, suppresses cell growth, and induces apoptosis in oral squamous cancer cells Oral Oncol 44 7 2008 639 645
104. G. Qi, I. Ogawa, Y. Kudo, M. Miyauchi, B.S. Siriwardena, and F. Shimamoto Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer Virchows Arch 450 3 2007 297 302
105. S. Paruthiyil, A. Cvoro, M. Tagliaferri, I. Cohen, E. Shtivelman, and D.C. Leitman Estrogen receptor beta causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2 Breast Cancer Res Treat 129 3 2011 777 784
106. C.Y. Chiu, K.K. Kuo, T.L. Kuo, K.T. Lee, and K.H. Cheng The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration Mol Cancer Res 10 3 2012 415 427
107. A.F. Soares, R.L. Xavier, M.C. da Costa Miguel, L.B. de Souza, and L.P. Pinto Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma Am J Otolaryngol 31 4 2010 266 271
108. C. Penas, V. Ramachandran, and N.G. Ayad The APC/C ubiquitin ligase: from cell biology to tumorigenesis Front Oncol 1 2011 60
109. R. Knecht, R. Elez, M. Oechler, C. Solbach, C. von Ilberg, and K. Strebhardt Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck Cancer Res 59 12 1999 2794 2797
110. J. LaBaer, M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Sandhu, and H.S. Chou New functional activities for the p21 family of CDK inhibitors Genes Dev 11 7 1997 847 862
111. J.A. Diehl, and C.J. Sherr A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase Mol Cell Biol 17 12 1997 7362 7374
112. R. Min, L. Siyi, Y. Wenjun, L. Shengwen, A. Ow, and W. Lizheng Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells Cancer Sci 2012
113. F.S. Giudice, A.M. Dal Vechio, A.C. Abrahao, F.F. Sperandio, and S. Pinto-Junior Ddos Different expression patterns of pAkt, NF-kappaB and cyclin D1 proteins during the invasion process of head and neck squamous cell carcinoma: an in vitro approach J Oral Pathol Med 40 5 2011 405 411
114. J.D. Moore, J. Yang, R. Truant, and S. Kornbluth Nuclear import of Cdk/cyclin complexes: identification of distinct mechanisms for import of Cdk2/cyclin E and Cdc2/cyclin B1 J Cell Biol 144 2 1999 213 224
115. M. Jackman, Y. Kubota, N. den Elzen, A. Hagting, and J. Pines Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm Mol Biol Cell 13 3 2002 1030 1045
116. A. Hagting, M. Jackman, K. Simpson, and J. Pines Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal Curr Biol 9 13 1999 680 689
117. J. Yang, H. Song, S. Walsh, E.S. Bardes, and S. Kornbluth Combinatorial control of cyclin B1 nuclear trafficking through phosphorylation at multiple sites J Biol Chem 276 5 2001 3604 3609
118. N. Kudo, N. Matsumori, H. Taoka, D. Fujiwara, E.P. Schreiner, and B. Wolff Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region Proc Natl Acad Sci USA 96 16 1999 9112 9117
119. M. Kong, E.A. Barnes, V. Ollendorff, and D.J. Donoghue Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction EMBO J 19 6 2000 1378 1388
120. K. Mishima, E. Yamada, K. Masui, T. Shimokawara, K. Takayama, and M. Sugimura Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma Mod Pathol 11 9 1998 886 891
121. S.O. de Sousa, R.A. Mesquita, D.S. Pinto Jr., and S. Gutkind Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma J Oral Pathol Med 31 2 2002 78 81
122. R. Vidya Priyadarsini, R. Senthil Murugan, and S. Nagini Aberrant activation of Wnt/beta-catenin signaling pathway contributes to the sequential progression of DMBA-induced HBP carcinomas Oral Oncol 2011
123. D. Saranath, S.E. Chang, L.T. Bhoite, R.G. Panchal, I.B. Kerr, and A.R. Mehta High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India Br J Cancer 63 4 1991 573 578
124. C. Albanese, K. Wu, M. D'Amico, C. Jarrett, D. Joyce, and J. Hughes IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf Mol Biol Cell 14 2 2003 585 599
125. T. Odajima, Y. Sasaki, N. Tanaka, Y. Kato-Mori, H. Asanuma, and T. Ikeda Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features Hum Pathol 36 3 2005 234 241
126. M.N. Ruesch, and L.A. Laimins Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity J Virol 71 7 1997 5570 5578
127. W.A. Bresnahan, I. Boldogh, E.A. Thompson, and T. Albrecht Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1 Virology 224 1 1996 150 160
128. M. Kundu, S. Sharma, A. De Luca, A. Giordano, J. Rappaport, and K. Khalili HIV-1 Tat elongates the G1 phase and indirectly promotes HIV-1 gene expression in cells of glial origin J Biol Chem 273 14 1998 8130 8136
129. C.E. Caldon, C.M. Sergio, J. Schutte, M.N. Boersma, R.L. Sutherland, and J.S. Carroll Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc Mol Cell Biol 29 17 2009 4623 4639
130. M. Moral, and J.M. Paramio Akt pathway as a target for therapeutic intervention in HNSCC Histol Histopathol 23 10 2008 1269 1278
131. L.K. Mullany, C.J. Nelsen, E.A. Hanse, M.M. Goggin, C.K. Anttila, and M. Peterson Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest J Biol Chem 282 29 2007 21244 21252
132. C. Freudlsperger, J.R. Burnett, J.A. Friedman, V.R. Kannabiran, Z. Chen, and C. Van Waes EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy Expert Opin Ther Targets 15 1 2011 63 74
133. E. Thirthagiri, C.M. Robinson, S. Huntley, M. Davies, L.F. Yap, and S.S. Prime Spindle assembly checkpoint and centrosome abnormalities in oral cancer Cancer Lett 258 2 2007 276 285
134. H. De Schutter, H. Geeraerts, E. Verbeken, and S. Nuyts Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only Oncol Rep 21 2 2009 507 513
135. F. Wolf, R. Sigl, and S. Geley '. The end of the beginning': cdk1 thresholds and exit from mitosis Cell Cycle 6 12 2007 1408 1411
136. E.A. Musgrove, C.E. Caldon, J. Barraclough, A. Stone, and R.L. Sutherland Cyclin D as a therapeutic target in cancer Nat Rev Cancer 11 8 2011 558 572
137. I. Androic, A. Kramer, R. Yan, F. Rodel, R. Gatje, and M. Kaufmann Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol BMC Cancer 8 2008 391
138. X.K. Li, M. Motwani, W. Tong, W. Bornmann, and G.K. Schwartz Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells Mol Pharmacol 58 6 2000 1287 1293
139. I. Gonzalez-Ramirez, C. Garcia-Cuellar, Y. Sanchez-Perez, and M. Granados-Garcia DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications Oral Dis 17 8 2011 771 778